.png)
Acute Myeloid Leukemia
Phase III Study for Acute Myeloid Leukemia Hailed as Landmark Trial
The American Journal of Managed Care (AJMC) published excerpts from a presentation by Dr. Andrew Wei at the 61st American Society of Hematology (ASH)
Rare Patient News. Well Done.
Positive Phase 2 Trial Results for Galactosemia Could Lead to Approval of New Therapy
- January 17, 2020
12 Healthcare Milestones that Defined the Decade
Can This Hormone That Regulates Sleep Treat Pulmonary Arterial Hypertension Symptoms?
Huntington’s Disease Patients Place Hopes in Clinical Trial
LATEST PATIENT WORTHY ARTICLES
Cervical Dystonia
How to Find Stillness in Your Life
If you are like me and probably most people, in today’s busy world it is a big challenge to be still and mentally at ease.
Costello Syndrome
How Whole Exome Sequencing Helps Diagnose Costello Syndrome
A diagnosis is something that is not always easy to attain. Without one, people cannot receive the best treatment for their conditions, miss out
.jpg)
Autoinflammatory Disease
ICYMI: A New Year, a New Autoinflammatory Disease, and a Promising New Drug
According to a recent article in Pharma Tutor, researchers at NHGRI, a division of the National Institute of Health, identified the biological cause of a
Ankylosing Spondylitis
A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials
According to a story from Acrofan, the biotechnology company Clover Pharmaceuticals Inc. has recently announced that the first patient has been dosed in its phase
Hansen's disease
Demystifying the Mysterious: Celebrating Awareness on World Leprosy Day
January 26th (the last Sunday of January) is World Leprosy Day! Mostly remembered as a Biblical disease that lead to shunning and societal ostracization, the
